Sorrento Escapes COVID-19 Investor Class Action
A California federal judge has dismissed a proposed class action from investors in Sorrento Therapeutics Inc. who claimed the company misled the public about its COVID-19 treatment, finding the investors didn't...To view the full article, register now.
Already a subscriber? Click here to view full article